Counterpoint Mutual Funds LLC Buys New Position in Cognex Corporation $CGNX

Key Points

• Counterpoint Mutual Funds opened a new position in Cognex, buying 17,220 shares valued at about $844,000 in the first quarter.
• Cognex reported strong quarterly results, with EPS of $0.34 versus $0.25 expected and revenue of $268.44 million, up 24.3% year over year. The company also raised its Q2 2026 EPS guidance to $0.40-$0.44.
• Wall Street sentiment remains positive: several firms raised price targets, and the stock carries a Moderate Buy consensus with an average target of $71.14. Meanwhile, insiders sold shares recently, including notable sales by Mark Fennell and Darren Marc Long.

Counterpoint Mutual Funds LLC purchased a new stake in Cognex Corporation (NASDAQ:CGNX - Free Report) in the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 17,220 shares of the scientific and technical instruments company's stock, valued at approximately $844,000.

Other institutional investors have also added to or reduced their stakes in the company. CIBC Private Wealth Group LLC grew its stake in Cognex by 74.8% during the 3rd quarter. CIBC Private Wealth Group LLC now owns 764 shares of the scientific and technical instruments company's stock valued at $35,000 after purchasing an additional 327 shares during the last quarter. Geneos Wealth Management Inc. raised its stake in shares of Cognex by 402.2% in the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company's stock worth $27,000 after purchasing an additional 736 shares during the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Cognex during the fourth quarter worth about $39,000. Miller Global Investments LLC acquired a new stake in shares of Cognex during the fourth quarter worth about $39,000. Finally, Larson Financial Group LLC boosted its position in Cognex by 202.7% in the fourth quarter. Larson Financial Group LLC now owns 1,105 shares of the scientific and technical instruments company's stock valued at $40,000 after buying an additional 740 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company's stock.

Cognex Price Performance

NASDAQ:CGNX opened at $67.80 on Friday. The firm has a market cap of $11.28 billion, a price-to-earnings ratio of 80.71 and a beta of 1.49. The company has a 50 day moving average price of $63.80 and a 200-day moving average price of $52.41. Cognex Corporation has a 1-year low of $31.77 and a 1-year high of $72.88.

Cognex (NASDAQ:CGNX - Get Free Report) last announced its quarterly earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.25 by $0.09. The firm had revenue of $268.44 million for the quarter, compared to the consensus estimate of $245.98 million. Cognex had a net margin of 13.62% and a return on equity of 10.89%. The firm's quarterly revenue was up 24.3% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.14 earnings per share. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. On average, sell-side analysts anticipate that Cognex Corporation will post 1.49 earnings per share for the current fiscal year.

Cognex Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, June 4th. Shareholders of record on Thursday, May 21st were paid a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a yield of 0.5%. The ex-dividend date was Thursday, May 21st. Cognex's dividend payout ratio is 40.48%.

Insiders Place Their Bets

In other news, insider Mark Fennell sold 64,873 shares of the stock in a transaction dated Monday, May 11th. The shares were sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the sale, the insider owned 11,263 shares of the company's stock, valued at approximately $755,184.15. This represents a 85.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Darren Marc Long sold 20,252 shares of the firm's stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the transaction, the vice president directly owned 3,990 shares of the company's stock, valued at approximately $264,696.60. The trade was a 83.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 224,847 shares of company stock worth $14,975,098 over the last ninety days. Corporate insiders own 1.70% of the company's stock.

Analysts Set New Price Targets

CGNX has been the subject of a number of recent research reports. Stephens raised their price target on shares of Cognex from $65.00 to $75.00 and gave the stock an "overweight" rating in a research report on Thursday, May 7th. The Goldman Sachs Group reissued a "buy" rating and set a $80.00 target price (up from $70.00) on shares of Cognex in a report on Monday, May 11th. Needham & Company LLC boosted their target price on shares of Cognex from $67.00 to $75.00 and gave the company a "buy" rating in a research report on Friday, May 8th. UBS Group set a $75.00 price target on Cognex in a research report on Tuesday, May 26th. Finally, JPMorgan Chase & Co. upgraded Cognex from a "neutral" rating to an "overweight" rating and lifted their price objective for the company from $65.00 to $75.00 in a research note on Tuesday, May 26th. Two investment analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and four have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average price target of $71.14.

About Cognex

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company's product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.